170 related articles for article (PubMed ID: 10506634)
1. Rapid switching from morphine to methadone in cancer patients with poor response to morphine.
Mercadante S; Casuccio A; Calderone L
J Clin Oncol; 1999 Oct; 17(10):3307-12. PubMed ID: 10506634
[TBL] [Abstract][Full Text] [Related]
2. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
[TBL] [Abstract][Full Text] [Related]
3. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
5. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
[TBL] [Abstract][Full Text] [Related]
6. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
[TBL] [Abstract][Full Text] [Related]
7. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
[TBL] [Abstract][Full Text] [Related]
8. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
Lawlor PG; Turner KS; Hanson J; Bruera ED
Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
[TBL] [Abstract][Full Text] [Related]
9. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
10. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
Mercadante S
Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
[TBL] [Abstract][Full Text] [Related]
11. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population.
Tse DM; Sham MM; Ng DK; Ma HM
Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853
[TBL] [Abstract][Full Text] [Related]
12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
13. Dose ratios between high dose oral morphine or equivalents and oral methadone.
Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
[TBL] [Abstract][Full Text] [Related]
14. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
15. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.
Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L
J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288
[TBL] [Abstract][Full Text] [Related]
16. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study.
Fredheim OM; Kaasa S; Dale O; Klepstad P; Landrø NI; Borchgrevink PC
Palliat Med; 2006 Jan; 20(1):35-41. PubMed ID: 16482756
[TBL] [Abstract][Full Text] [Related]
17. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
18. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
[TBL] [Abstract][Full Text] [Related]
20. Switching to methadone: 'ad libitum' or fixed dose ratio?
Mercadante S
Palliat Med; 2004 Jan; 18(1):71; author reply 72. PubMed ID: 14982211
[No Abstract] [Full Text] [Related]
[Next] [New Search]